Sapiens International Corporation N.V.
(Registrant)
|
|||
Date: March 10, 2010
|
By:
|
/s/ Roni Giladi | |
Roni Giladi | |||
Chief Financial Officer | |||
|
·
|
Q4/2009 Revenues increased 7% compared to Q4 2008 to $11.77 million
|
|
·
|
Q4/2009 Non-GAAP Net Income of $1.87 million
|
|
·
|
Non-GAAP annual operating profit almost doubled to $6.53 million compared to $3.38 million in 2008
|
|
·
|
$11.17 million in cash and cash equivalents , and zero debt, as of December 31, 2009
|
|
·
|
Annual revenue grew to $45.7 million
|
|
·
|
Non-GAAP annual operating profit almost doubled to $6.53 million compared to $3.38 million in 2008
|
|
·
|
Annual net income significantly grew to $4.2 million in 2009, compared to loss of $334,000 in 2008
|
|
·
|
Total shareholders’ equity of $26.4 million in December 2009 which represents 57.7% of the total balance sheet, compared to 48.4% in December 2008.
|
For the three months ended
|
For the year ended
|
|||||||||||||||
|
12/31/2009
|
12/31/2008
|
12/31/2009
|
12/31/2008
|
||||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
|||||||||||||
U.S GAAP basis
|
||||||||||||||||
Revenues
|
11,767 | 11,007 | 45,695 | 43,534 | ||||||||||||
Operating profit
|
1,512 | 774 | 5,341 | 2,485 | ||||||||||||
Net income (loss)
|
1,262 | 1,007 | 4,201 | (344 | ) | |||||||||||
Basic earning (loss) per share
|
0.06 | 0.05 | 0.19 | (0.02 | ) | |||||||||||
Diluted earning (loss) per share
|
0.06 | 0.05 | 0.19 | (0.02 | ) | |||||||||||
NonGAAP
|
||||||||||||||||
Revenues
|
11,767 | 11,007 | 45,695 | 43,534 | ||||||||||||
Operating profit
|
2,118 | 1,030 | 6,531 | 3,378 | ||||||||||||
Net income
|
1,868 | 1,263 | 5,391 | 549 | ||||||||||||
Basic earning per share
|
0.09 | 0.06 | 0.25 | 0.03 | ||||||||||||
Diluted earning per share
|
0.09 | 0.06 | 0.25 | 0.03 |
SAPIENS INTERNATIONAL CORPORATION N.V.
|
Condensed Consolidated Balance Sheets
|
(U.S. Dollars in thousands)
|
12/31/2009
|
12/31/2008
|
|||||||
(Unaudited)
|
(Audited)
|
|||||||
Assets
|
||||||||
Cash and cash equivalents
|
$ | 11,172 | $ | 7,938 | ||||
Trade receivables, net
|
5,132 | 6,860 | ||||||
Other current assets
|
2,621 | 2,565 | ||||||
Total current assets
|
18,925 | 17,363 | ||||||
Property and equipment, net
|
897 | 1,055 | ||||||
Other assets, net
|
25,952 | 26,759 | ||||||
Total assets
|
$ | 45,774 | $ | 45,177 | ||||
Liabilities and shareholders' equity
|
||||||||
Current maturities of long-term debt and convertible debentures
|
$ | - | $ | 5,745 | ||||
Trade payables
|
1,197 | 1,500 | ||||||
Other liabilities and accrued expenses
|
10,199 | 9,716 | ||||||
Deferred revenue
|
6,991 | 4,908 | ||||||
Total current liabilities
|
18,387 | 21,869 | ||||||
Long-term debt and other long-term liabilities
|
972 | 1,432 | ||||||
Shareholders' equity
|
26,415 | 21,876 | ||||||
Total liabilities and shareholders' equity
|
$ | 45,774 | $ | 45,177 |
SAPIENS INTERNATIONAL CORPORATION N.V.
|
Condensed Consolidated Statements of Operations
|
(U.S. Dollars in thousands, except per share amounts)
|
For the three months ended
|
For the year ended
|
|||||||||||||||
12/31/2009
|
12/31/2008
|
12/31/2009
|
12/31/2008
|
|||||||||||||
Unaudited
|
Unaudited
|
Unaudited
|
Audited
|
|||||||||||||
Revenues
|
$ | 11,767 | $ | 11,007 | $ | 45,695 | $ | 43,534 | ||||||||
Cost of revenues
|
$ | 7,388 | $ | 7,010 | $ | 26,571 | $ | 26,457 | ||||||||
Gross Profit
|
4,379 | 3,997 | 19,124 | 17,077 | ||||||||||||
Operating expenses
|
||||||||||||||||
Research and development, net
|
$ | 950 | $ | 1,352 | $ | 2,735 | $ | 3,884 | ||||||||
Selling, marketing, general and administrative
|
$ | 1,917 | $ | 1,871 | $ | 11,048 | $ | 10,708 | ||||||||
Operating Profit
|
1,512 | 774 | 5,341 | 2,485 | ||||||||||||
Financial expenses (income), net
|
$ | 132 | $ | (530 | ) | $ | 880 | $ | 2,236 | |||||||
Other expenses, net
|
$ | 118 | 291 | $ | 260 | 552 | ||||||||||
Net Income (Loss)
|
$ | 1,262 | $ | 1,013 | $ | 4,201 | $ | (303 | ) | |||||||
Attributetable to non-controlling interest
|
$ | - | $ | 6 | $ | - | $ | 41 | ||||||||
Net income (Loss) attributable to Sapiens
|
$ | 1,262 | $ | 1,007 | $ | 4,201 | $ | (344 | ) | |||||||
Earning (loss) per share
|
||||||||||||||||
Basic
|
$ | 0.06 | $ | 0.05 | $ | 0.19 | $ | (0.02 | ) | |||||||
Diluted
|
$ | 0.06 | $ | 0.05 | $ | 0.19 | $ | (0.02 | ) | |||||||
Weighted average number of shares used to computation of earning (loss) per share
|
||||||||||||||||
Basic
|
21,591 | 21,577 | 21,591 | 21,550 | ||||||||||||
Diluted
|
21,593 | 21,600 | 21,592 | 21,550 |
SAPIENS INTERNATIONAL CORPORATION N.V.
|
Reconciliation of GAAP to Non-GAAP results
|
(U.S. Dollars in thousands, except per share amounts)
|
For the three months ended
|
For the year ended
|
|||||||||||||||
12/31/2009
|
12/31/2008
|
12/31/2009
|
12/31/2008
|
|||||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
|||||||||||||
GAAP operating profit
|
1,512 | 774 | 5,341 | 2,485 | ||||||||||||
Amortization of intangibles
|
1,352 | 989 | 4,623 | 4,224 | ||||||||||||
Capitalization of software development
|
(851 | ) | (783 | ) | (3,692 | ) | (3,496 | ) | ||||||||
Stock-based compensation
|
105 | 50 | 259 | 165 | ||||||||||||
Total adjustments to GAAP
|
606 | 256 | 1,190 | 893 | ||||||||||||
Non-GAAP operating profit
|
2,118 | 1,030 | 6,531 | 3,378 | ||||||||||||
GAAP net income (loss)
|
1,262 | 1,007 | 4,201 | (344 | ) | |||||||||||
Total adjustments to GAAP as above
|
606 | 256 | 1,190 | 893 | ||||||||||||
Non-GAAP net income
|
1,868 | 1,263 | 5,391 | 549 | ||||||||||||
Non-GAAP basic earnings per share
|
0.09 | 0.06 | 0.25 | 0.03 | ||||||||||||
Non-GAAP diluted earnings per share
|
0.09 | 0.06 | 0.25 | 0.03 | ||||||||||||
Weighted average number of shares used to computation of earning (loss) per share
|
||||||||||||||||
Basic
|
21,591 | 21,577 | 21,591 | 21,550 | ||||||||||||
Diluted
|
21,593 | 21,600 | 21,592 | 21,550 |